Review, 2015
What do we know about PMS and PMDD and how are they treated?
PMS affects 30 to 40 percent of reproductive-age women and PMDD affects 3 to 8 percent. Serotonergic antidepressants are the most effective treatment, but oral contraceptives, lifestyle changes, cognitive behavioral therapy, and herbal supplements are also available options.
What they did
This is a literature review that summarizes findings from many studies about PMS and PMDD.
What they found
PMS is characterized by recurrent moderate-to-severe affective, physical, and behavioral symptoms that occur during the luteal phase and disappear within a few days of menstruation. PMDD is a more severe and disabling form. The cause is not fully understood but involves increased sensitivity to normal hormonal changes and neurotransmitter abnormalities. The Daily Record of Severity of Problems (DRSP) is the standard diagnostic tool.
What it means for you
This review helps explain that PMS is common and treatable. Clinicians should consider each patient's situation individually when choosing between medication, behavioral therapy, and lifestyle approaches.
30-40%
Prevalence of PMS
3-8%
Prevalence of PMDD
About the study
- Original title
- Premenstrual syndrome: A mini review
- Authors
- Ryu A, Kim TH
- Journal
- Maturitas
- Year
- 2015
- Study design
- Review
- What was tested
- Literature review of treatments, not a study of one intervention
- Read the paper
- doi.org/10.1016/j.maturitas.2015.08.010
Topics
Related studies
Survey study, 2026
What are the causes, diagnosis, and treatments for PMS and PMDD?
Study, 2022
What are the symptoms, causes, and treatments of PMS and PMDD?
Review, 2017
What causes PMDD and what are the best treatments?
Randomised trial, 2010
What treatments work for premenstrual syndrome?
Review, 2008
What medications are FDA-approved for treating PMDD?
Cohort study, 2022
What are PMS and PMDD and how should they be diagnosed and treated?